Cruise lines are big losers on Wall Street this week -- and there are few winnersCNN Business • 02/28/20
How Gilead Sciences Is Driving Forty Seven and Trillium Therapeutics Higher TodayThe Motley Fool • 02/28/20
Biotech company Forty Seven surges 30% after hours on report of Gilead interestMarket Watch • 02/28/20
Coronavirus Infects Wall Street — Can Gilead, Moderna Ride To The Rescue?Investors Business Daily • 02/28/20
Why Inovio Pharmaceuticals, Gilead Sciences, Moderna, and Novavax Are All Jumping TodayThe Motley Fool • 02/27/20
Gilead Sciences Initiates Late-Stage Testing of Its Promising Coronavirus DrugThe Motley Fool • 02/26/20
Airport Screeners Are Likely Missing 2 Out of 3 COVID-19 Carriers, Researchers WarnThe Motley Fool • 02/26/20
U.S. Health Officials Start First Clinical Trial With Gilead Sciences' Experimental Coronavirus TreatmentThe Motley Fool • 02/25/20